Actively Recruiting
Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
Led by Centre Hospitalier Universitaire de Nice · Updated on 2025-09-11
735
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Immune response to influenza vaccine in patients with chronic renal insufficiency.
CONDITIONS
Official Title
Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chronic renal failure patient at stage 4 or 5 (estimated GFR < 30mL/min/1.73m2), or dialysis patient, or renal transplant patient regardless of GFR
- Age 18 years or older
- Indication for influenza vaccination
- Provided free and informed consent
You will not qualify if you...
- Known allergy to influenza vaccine or egg proteins
- Previous influenza vaccination for the current season
- Current infection
- Current acute illness
- Treatment of rejection within the previous 3 months
- Renal transplantation with induction within the previous 6 months
- Immunosuppressive treatment including CTLA4 agonist, complement inhibitor, or anti-CD20
- Polyvalent immunoglobulin infusion within the preceding 3 months
- Vulnerable persons such as minors, adults under guardianship or trusteeship, persons deprived of liberty, or those unable to speak French
- Not affiliated to Social Security
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Nice - Hôpital Pasteur 2
Nice, Alpes-Maritimes, France, 06000
Actively Recruiting
Research Team
G
GOSSET Clément, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here